Bedoukian   RussellIPM   RussellIPM   Piezoelectric Micro-Sprayer


Home
Animal Taxa
Plant Taxa
Semiochemicals
Floral Compounds
Semiochemical Detail
Semiochemicals & Taxa
Synthesis
Control
Invasive spp.
References

Abstract

Guide

Alphascents
Pherobio
InsectScience
E-Econex
Counterpart-Semiochemicals
Print
Email to a Friend
Kindly Donate for The Pherobase

« Previous AbstractBreath biomarkers of whole-body gamma irradiation in the Gottingen minipig    Next AbstractBreath biomarkers of total body irradiation in non-human primates »

J Breath Res


Title:Breath mass ion biomarkers of breast cancer
Author(s):Phillips M; Cataneo R; Lebauer C; Mundada M; Saunders C;
Address:"Menssana Research INC, Suite 517, 211 Warren Street, Newark, NJ 07103, USA, Newark, New Jersey, 07103,UNITED STATES. 211 Warren Street,Menssana Research INC, Newark, New Jersey,UNITED STATES. 211 Warren Street, ,Schmitt & Associates, Newark, New Jersey,UNITED STATES. University of Western Australia, Crawley, Western Australia,AUSTRALIA"
Journal Title:J Breath Res
Year:2017
Volume:20161219
Issue:1
Page Number:16004 -
DOI: 10.1088/1752-7163/aa549b
ISSN/ISBN:1752-7163 (Electronic) 1752-7155 (Linking)
Abstract:"BACKGROUND: Breath volatile organic compounds (VOCs) contain biomarkers of breast cancer that are detectable with gas chromatography mass spectrometry (GC MS). However, chemical identification of breath VOC biomarkers may be erroneous because spectral matching can misidentify their structure. Breath mass ions detected with GC MS have been proposed as intrinsically robust biomarkers because they can be identified without spectral matching. We investigated whether breath mass ion biomarkers could identify breast cancer. METHODS: We re-analyzed data from a previous study of breath VOCs in 54 women with biopsy-proven breast cancer and in 204 healthy controls. Subjects were randomly assigned to a training set (2/3) and a test set (1/3). Chromatograms were processed with metabolomic analysis software (XCMS in R) in order to generate a table listing retention times with their associated ion masses and intensities, and binned into a series of 5 sec retention time segments. In the training set, mass ions in each time segment were ranked according to their diagnostic accuracy i.e. the area under curve (AUC) of the receiver operating characteristic (ROC) curve. We employed multiple Monte Carlo simulations to select the biomarker mass ions in each time segment that identified breast cancer with greater than random accuracy and combined those with the highest diagnostic accuracy in a predictive algorithm using multivariate weighted digital analysis (WDA). We then employed this algorithm to predict the diagnosis in the test set. RESULTS: The training set WDA algorithm employing 21 mass ion biomarkers identified breast cancer with ROC curve AUC = 0.79. In the test set, this algorithm predicted breast cancer with ROC curve AUC = 0.77. CONCLUSION: Breath mass ions biomarkers accurately identified women with breast cancer and could potentially be used in early diagnosis and treatment monitoring"
Keywords:Breast cancer Breath Cancer detection Mass ions Volatile organic compound;
Notes:"PubMed-not-MEDLINEPhillips, Michael Cataneo, Renee Lebauer, Cassie Mundada, Mayur Saunders, Christobel eng England 2016/12/20 J Breath Res. 2017 Mar; 11(1):016004. doi: 10.1088/1752-7163/aa549b. Epub 2016 Dec 19"

 
Back to top
 
Citation: El-Sayed AM 2024. The Pherobase: Database of Pheromones and Semiochemicals. <http://www.pherobase.com>.
© 2003-2024 The Pherobase - Extensive Database of Pheromones and Semiochemicals. Ashraf M. El-Sayed.
Page created on 27-12-2024